Table 2.
EORTC QLQ-C30 scores of patients who underwent transanal endoscopic microsurgery
| Scale | Time; mean (SD) | p value | |
|---|---|---|---|
| Preoperative | Postoperative | ||
| Function* | |||
| Physical | 90.0 (16.3) | 90.7 (15.7) | 0.48 |
| Role | 92.8 (22.2) | 97.2 (10.8) | 0.50 |
| Emotional | 75.9 (25.1) | 80.0 (23.4) | 0.32 |
| Cognitive | 92.8 (18.9) | 93.3 (12.1) | 0.77 |
| Social | 91.7 (20.9) | 96 (10.4) | 0.25 |
| Global health status | 73.9 (22.0) | 78.6 (17.7) | 0.10 |
| Symptom† | |||
| Fatigue | 5.9 (11.6) | 7.8 (12.4) | 0.69 |
| Nausea/vomiting | 6.1 (20.2) | 4.4 (19.0) | 0.25 |
| Pain | 10.1 (24.1) | 10.0 (20.8) | > 0.99 |
| Dyspnoea | 10.1 (23.7) | 13.3 (24.1) | 0.50 |
| Sleep disturbance | 76.7 (27.9) | 74.4 (27.2) | 0.75 |
| Appetite loss | 95.4 (11.7) | 92.2 (16.8) | 0.50 |
| Constipation | 91.1 (17.4) | 86.7 (22.5) | 0.34 |
| Diarrhea | 72.2 (31.2) | 90.0 (15.5) | 0.002 |
| Financial worries | 93.3 (22.1) | 95.6 (19.0) | > 0.99 |
EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30;8 SD = standard deviation.
*
High score reflects better function.
†
Low score indicates fewer symptoms.